Tomasic G - Search Results

1

Efficacy of adjuvant chemotherapy according to Prion protein expression in patients with estrogen receptor-negative breast cancer.

Meslin F, Conforti R, Mazouni C, Morel N, Tomasic G, Drusch F, Yacoub M, Sabourin JC, Grassi J, Delaloge S, Mathieu MC, Chouaib S, Andre F, Mehrpour M. Meslin F, et al. Among authors: tomasic g. Ann Oncol. 2007 Nov;18(11):1793-8. doi: 10.1093/annonc/mdm406. Epub 2007 Sep 14. Ann Oncol. 2007. PMID: 17872899 Free article.

2

Breast cancer molecular subclassification and estrogen receptor expression to predict efficacy of adjuvant anthracyclines-based chemotherapy: a biomarker study from two randomized trials.

Conforti R, Boulet T, Tomasic G, Taranchon E, Arriagada R, Spielmann M, Ducourtieux M, Soria JC, Tursz T, Delaloge S, Michiels S, Andre F. Conforti R, et al. Among authors: tomasic g. Ann Oncol. 2007 Sep;18(9):1477-83. doi: 10.1093/annonc/mdm209. Epub 2007 May 21. Ann Oncol. 2007. PMID: 17515403 Free article. Clinical Trial.

3

Expression patterns and predictive value of phosphorylated AKT in early-stage breast cancer.

Andre F, Nahta R, Conforti R, Boulet T, Aziz M, Yuan LX, Meslin F, Spielmann M, Tomasic G, Pusztai L, Hortobagyi GN, Michiels S, Delaloge S, Esteva FJ. Andre F, et al. Among authors: tomasic g. Ann Oncol. 2008 Feb;19(2):315-20. doi: 10.1093/annonc/mdm429. Epub 2007 Sep 5. Ann Oncol. 2008. PMID: 17804473 Free article.

4

Association between the nuclear to cytoplasmic ratio of p27 and the efficacy of adjuvant polychemotherapy in early breast cancer.

Andre F, Conforti R, Moeder CB, Mauguen A, Arnedos M, Berrada N, Delaloge S, Tomasic G, Spielmann M, Esteva FJ, Rimm DL, Michiels S. Andre F, et al. Among authors: tomasic g. Ann Oncol. 2012 Aug;23(8):2059-2064. doi: 10.1093/annonc/mdr569. Epub 2012 Jan 11. Ann Oncol. 2012. PMID: 22241898 Free article. Clinical Trial.

5

CXCR4 expression in early breast cancer and risk of distant recurrence.

Andre F, Xia W, Conforti R, Wei Y, Boulet T, Tomasic G, Spielmann M, Zoubir M, Berrada N, Arriagada R, Hortobagyi GN, Hung MC, Pusztai L, Delaloge S, Michiels S, Cristofanilli M. Andre F, et al. Among authors: tomasic g. Oncologist. 2009 Dec;14(12):1182-8. doi: 10.1634/theoncologist.2009-0161. Epub 2009 Nov 25. Oncologist. 2009. PMID: 19939894 Free article. Clinical Trial.

6

The differential response to chemotherapy of ovarian metastases from colorectal carcinoma.

Goéré D, Daveau C, Elias D, Boige V, Tomasic G, Bonnet S, Pocard M, Dromain C, Ducreux M, Lasser P, Malka D. Goéré D, et al. Among authors: tomasic g. Eur J Surg Oncol. 2008 Dec;34(12):1335-9. doi: 10.1016/j.ejso.2008.03.010. Epub 2008 May 2. Eur J Surg Oncol. 2008. PMID: 18455357

7

HER2 overexpression and doxorubicin in adjuvant chemotherapy for resectable breast cancer.

Moliterni A, Ménard S, Valagussa P, Biganzoli E, Boracchi P, Balsari A, Casalini P, Tomasic G, Marubini E, Pilotti S, Bonadonna G. Moliterni A, et al. Among authors: tomasic g. J Clin Oncol. 2003 Feb 1;21(3):458-62. doi: 10.1200/JCO.2003.04.021. J Clin Oncol. 2003. PMID: 12560435 Clinical Trial.

8

Prospective study of cutaneous side-effects associated with the BRAF inhibitor vemurafenib: a study of 42 patients.

Boussemart L, Routier E, Mateus C, Opletalova K, Sebille G, Kamsu-Kom N, Thomas M, Vagner S, Favre M, Tomasic G, Wechsler J, Lacroix L, Robert C. Boussemart L, et al. Among authors: tomasic g. Ann Oncol. 2013 Jun;24(6):1691-7. doi: 10.1093/annonc/mdt015. Epub 2013 Feb 13. Ann Oncol. 2013. PMID: 23406731 Free article.

9

KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab.

Lièvre A, Bachet JB, Boige V, Cayre A, Le Corre D, Buc E, Ychou M, Bouché O, Landi B, Louvet C, André T, Bibeau F, Diebold MD, Rougier P, Ducreux M, Tomasic G, Emile JF, Penault-Llorca F, Laurent-Puig P. Lièvre A, et al. Among authors: tomasic g. J Clin Oncol. 2008 Jan 20;26(3):374-9. doi: 10.1200/JCO.2007.12.5906. J Clin Oncol. 2008. PMID: 18202412

10

p53 and bcl-2 expression correlates with clinical outcome in a series of node-positive breast cancer patients.

Silvestrini R, Benini E, Veneroni S, Daidone MG, Tomasic G, Squicciarini P, Salvadori B. Silvestrini R, et al. Among authors: tomasic g. J Clin Oncol. 1996 May;14(5):1604-10. doi: 10.1200/JCO.1996.14.5.1604. J Clin Oncol. 1996. PMID: 8622078

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters